- Home
- ATPC vs ONCO Comparison
ATPC vs ONCO Comparison
Compare ATPC & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- ONCO
- Stock Information
- Founded
- ATPC 2016
- ONCO 2018
- Country
- ATPC Malaysia
- ONCO United States
- Employees
- ATPC N/A
- ONCO N/A
- Industry
- ATPC Medical/Nursing Services
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- ATPC Health Care
- ONCO Health Care
- Exchange
- ATPC Nasdaq
- ONCO Nasdaq
- Market Cap
- ATPC 4.6M
- ONCO 4.6M
- IPO Year
- ATPC N/A
- ONCO 2022
- Fundamental
- Price
- ATPC $1.33
- ONCO $0.53
- Analyst Decision
- ATPC
- ONCO
- Analyst Count
- ATPC 0
- ONCO 0
- Target Price
- ATPC N/A
- ONCO N/A
- AVG Volume (30 Days)
- ATPC 4.6M
- ONCO 17.2M
- Earning Date
- ATPC 02-15-2025
- ONCO 12-10-2024
- Dividend Yield
- ATPC N/A
- ONCO N/A
- EPS Growth
- ATPC N/A
- ONCO N/A
- EPS
- ATPC N/A
- ONCO N/A
- Revenue
- ATPC $1,354,042.00
- ONCO $1,870,605.00
- Revenue This Year
- ATPC N/A
- ONCO N/A
- Revenue Next Year
- ATPC N/A
- ONCO N/A
- P/E Ratio
- ATPC N/A
- ONCO N/A
- Revenue Growth
- ATPC N/A
- ONCO N/A
- 52 Week Low
- ATPC $1.07
- ONCO $0.32
- 52 Week High
- ATPC $19.60
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- ATPC 49.56
- ONCO 41.58
- Support Level
- ATPC $1.26
- ONCO $0.46
- Resistance Level
- ATPC $2.93
- ONCO $0.76
- Average True Range (ATR)
- ATPC 0.19
- ONCO 0.23
- MACD
- ATPC 0.02
- ONCO 0.05
- Stochastic Oscillator
- ATPC 14.02
- ONCO 9.97
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.